Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 30613
Event :SMi's 4th Annual 3D Cell Culture Conference

Dates :Tuesday February 18th, 2020 - Thursday February 20th, 2020

Location :Copthorne Tara Hotel London Kensington
Scarsdale Place
W8 5SY London, United Kingdom

Type :Conference & Seminar - International audience

Accreditation :--


 

Further information

 

CHAIRED BY:
Philip Hewitt, UK and Eurotox Registered Toxicologist, Global Head of Early Investigative Toxicology, Merck Healthcare KGaA
Stefan Przyborski, Professor of Cell Technology, Durham university
 
Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity.
 
SMi’s 3D Cell Culture Conference will explore advances of organ and lab-on-a-chip, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field.
 
Bioprinting has become increasingly efficient and accurate in building in vitro tissue models with the potential to provide pathologically relevant responses and model human disease mechanisms. Bio-printed structures yield phenotypic endpoints that are comparable with clinical studies and can provide a realistic prediction of clinical efficacy. The use of bioprinting is growing in big pharma companies as an alternative to organ-on-a-chip systems.
 
For the first time ever the NEW 3D Bioprinting Focus Day on 18 February 2020 will explore case studies from big pharma, biotech’s and academia exploring how bioprinting is being used in industry highlighting projects looking at stem cell therapy, drug screening and extracellular matrix scaffolds.
 
WHO SHOULD ATTEND?
Biotech / Pharma Companies - Team Leader, Junior Principle investigator, Cell and Molecular Scientist, Chief Scientific Officer, Deputy Director, Manager, Founder, CEO, Head, Director, Programme Manager, Lab Head, Toxicologist
Academia Professor - Cell Technology, Stem Cell Sciences, Biochemistry, Protein Technology and Tissue Engineering
Solution Providers – Manager, Head of, CEO, Director, Founder, Account Manager, President, CSO, Executive, Managing Director
 
Booking https://go.evvnt.com/520854-0?pid=4319
Tickets https://go.evvnt.com/520854-1?pid=4319
Brochure https://go.evvnt.com/520854-3?pid=4319
Inquiries https://go.evvnt.com/520854-4?pid=4319
Website https://go.evvnt.com/520854-5?pid=4319
Sponsor https://go.evvnt.com/520854-6?pid=4319
 
Prices:
Conference & Focus Day GBP 2398.00
Conference Only GBP 1499.00
Focus Day Only GBP 899.00
Promotional Literature Distribution at event GBP 999.00
Documentation - Conference Presentations GBP 499.00
 
Speakers: Petra Kerscher, Senior Scientist, Merck KGaA, Amna Magzoub, R&D Engineer, Novo Nordisk A/S Lars Growth Grunnet, Senior Scientist, Novo Nordisk, Stefan Przyborski, Professor of Cell Technology, University of Durham, Philip Hewitt, UK and Eutrotox Registered Toxicologist, Head of Early Investigative Technology, Merck, Amna Magzoub, R&D Engineer, Novo Nordisk A/S, Lars Growth Grunnet, Senior Scientist, Novo Nordisk, Sarah Trenfi eld, Director of Innovation, FabRx Ltd, Hansjoerg Keller, Senior Investigator I, Musculoskeletal Disease Area, Novartis, Jason Ekert, Head Complex In Vitro Models, GSK, Petra Kerscher, Senior Scientist, Merck, Hansjoerg Keller, Senior Investigator I, Novartis, Kenny Dalgarno, Professor of Manufacturing Engineering, Newcastle University Gino Van Heeke, CSO, Engitix, Naheem Yaqub, PhD Candidate, University College London in Collaboration with GSK, Veronique Barban, Expert Virology, Research and Nonclinical Safety Department, Sanofi Pasteur, Floriane Groell, Senior Scientist, Novartis Pharma AG, Samuel Jackson, Programme Manager, Disease Models Efficacy and Safety Pharmacology, NC3Rs, Kenny Dalgarno, Professor of Manufacturing Engineering, Newcastle University, Maxime Feyeux, Co-Founder, President, CSO, TreeFrog Therapeutics, Michele Zagnoni, Reader, University of Strathclyde, Leonard Both, Senior Quality Assessor, Biologicals/Biotechnology Unit, MHRA, Wendy Rowan, Scientific Director, Novel Human Genetics Research Unit, GSK, Alexander D. Graham, Investigator Scientist, MRC Harwell Institute, Ellen J. Wehrens, Scientific Writer, Imaging Department, Princess Máxima Center for Pediatric Oncology, Rajesh Pandey, Postdoctoral Training Fellow, MRC Harwell Institute
 
Time: on Tuesday February 18, 2020 at 8:30 am (ends Thursday February 20, 2020 at 5:30 pm)
 

Location

Map and directions
Conference address :
Copthorne Tara Hotel London Kensington
Scarsdale Place
W8 5SY London
United Kingdom
Map and directions

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama

Details

SMi's 4th Annual 3D Cell Culture Conference Medicine
--
Everyone
-- -- --
English

Other

For more information on SMi's 4th Annual 3D Cell Culture Conference, plsase contactr SMi Group

To obtain a letter of invitation, you must be logged

Log to my account
Register on Doctorama


Recommend this event